(1)
Kubica, K.; Mazurek, A. VEMURAFENIB AS A SELECTIVE INHIBITOR OF THE SERINE THREONINE-PROTEIN KINASE B-RAF, USED IN THE TREATMENT OF MELANOMA. Prospect. Pharm. Sci. 2016, 14, 52-56.